# FDA Inspection 1144629 - Porton Biopharma Limited - May 21, 2021

Source: https://www.keypedia.com/records/fda_inspections/porton-biopharma-limited/69d89fc5-c800-4e36-a7ca-28b8a5b53943
Source feed: FDA_Inspections

> FDA Inspection 1144629 for Porton Biopharma Limited on May 21, 2021. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1144629
- Company Name: Porton Biopharma Limited
- Inspection Date: 2021-05-21
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1061383 - 2018-08-01](https://www.keypedia.com/records/fda_inspections/porton-biopharma-limited/5840a372-e08c-49a1-8153-205ea3b16566)
- [FDA Inspection 981848 - 2016-03-18](https://www.keypedia.com/records/fda_inspections/porton-biopharma-limited/52dd2fae-01b6-492a-8a35-f672f76c73fb)

Company: https://www.keypedia.com/companies/porton-biopharma-limited/88a6cb10-7c20-4684-bad9-9352fb509563

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c